Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today ...

Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.